Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Sahin U, Schuler M, Richly H, Bauer S, et al. A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer. Eur J Cancer 2018;100:17-26.
PMID: 29936063


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016